T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
RTX Corp
RTX
|
$641M |
| 2 |
PTC
PTC
|
$625M |
| 3 |
Humana
HUM
|
$414M |
| 4 |
Exelon
EXC
|
$349M |
| 5 |
Biogen
BIIB
|
$348M |
Top Sells
| 1 |
BKI
Black Knight, Inc. Common Stock
BKI
|
$892M |
| 2 |
Apple
AAPL
|
$758M |
| 3 |
Danaher
DHR
|
$501M |
| 4 |
Microsoft
MSFT
|
$470M |
| 5 |
Intercontinental Exchange
ICE
|
$441M |
Sector Composition
| 1 | Technology | 22.36% |
| 2 | Healthcare | 21.9% |
| 3 | Financials | 12% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
BridgeBio Pharma
BBIO
$9.92B
| $26.3M | 0.02% |
+995,632
| New | +$26.3M |
|
452
Savers
SVV
$1.94B
| $26.1M | 0.02% |
1,400,000
| – | – |
|
453
Elanco Animal Health
ELAN
$8.9B
| $26M | 0.02% |
+2,309,506
| New | +$26M |
|
454
Compass Minerals
CMP
$787M
| $25.9M | 0.02% |
928,139
+317,836
| +52% | +$8.88M |
|
455
Immatics
IMTX
$659M
| $25.8M | 0.02% |
2,230,836
+17,721
| +0.8% | +$205K |
|
456
MacroGenics
MGNX
$115M
| $25.6M | 0.02% |
5,491,952
+29,300
| +0.5% | +$137K |
|
457
Sun Country Airlines
SNCY
$703M
| $25.5M | 0.02% |
1,717,507
+68,320
| +4% | +$1.01M |
|
458
Huron Consulting
HURN
$2.38B
| $25.4M | 0.02% |
244,093
-384,800
| -61% | -$40.1M |
|
459
Blue Bird Corp
BLBD
$1.83B
| $25.2M | 0.02% |
1,179,329
-50,800
| -4% | -$1.08M |
|
460
Columbia Financial
CLBK
$1.56B
| $24.4M | 0.02% |
1,552,039
+1,177
| +0.1% | +$18.5K |
|
|
HCP
461
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $23.2M | 0.02% |
1,014,125
-20,900
| -2% | -$477K |
|
462
Agios Pharmaceuticals
AGIO
$2.24B
| $23M | 0.02% |
930,051
| – | – |
|
463
Blue Foundry Bancorp
BLFY
$200M
| $23M | 0.02% |
2,742,120
| – | – |
|
464
Air Lease Corp
AL
$7.17B
| $22.8M | 0.02% |
579,074
-2,362,062
| -80% | -$93.1M |
|
465
Academy Sports + Outdoors
ASO
$3.28B
| $22.6M | 0.02% |
478,317
-251,586
| -34% | -$11.9M |
|
466
Opendoor
OPEN
$3.51B
| $22.6M | 0.02% |
8,549,147
-1,820,496
| -18% | -$4.81M |
|
467
Kymera Therapeutics
KYMR
$2.87B
| $22.4M | 0.02% |
1,610,496
| – | – |
|
468
Middleby
MIDD
$6.91B
| $22.2M | 0.02% |
173,082
+45,989
| +36% | +$5.89M |
|
469
Repare Therapeutics
RPTX
$68.3M
| $21.7M | 0.02% |
1,796,906
-106,300
| -6% | -$1.28M |
|
470
Southern First Bancshares
SFST
$366M
| $21.5M | 0.02% |
799,022
+828
| +0.1% | +$22.3K |
|
471
Alpha Metallurgical Resources
AMR
$1.84B
| $20.9M | 0.01% |
+80,638
| New | +$20.9M |
|
472
RAPT Therapeutics
RAPT
$195M
| $20.8M | 0.01% |
1,251,892
+9,305
| +0.7% | +$155K |
|
473
Petco
WOOF
$1.02B
| $20.5M | 0.01% |
5,019,607
+223,373
| +5% | +$914K |
|
474
Main Street Capital
MAIN
$5.89B
| $20M | 0.01% |
492,307
| – | – |
|
475
Essential Utilities
WTRG
$10.9B
| $19.8M | 0.01% |
575,987
+25,493
| +5% | +$875K |
|